Rocket One Inc. RKTO
0.46 USD +0.01 (+2.87%)
At closeNov 4, 2026, 4:00 AM EST
0.48 +0.01 +2.79%
Pre-market · Nov 4, 4:00 AM ET
0.4301 Day range 0.4989
0.4301 52-week range 2.45
- YTD
- -53.31%
- 1 year
- -66.99%
- Market cap
- 11.51M
- EPS (ttm)
- -0.82
- YTD return
- -53.31%
- 1-year return
- -66.99%
- Volume
- 1.26M
- Avg volume
- 364.05K
- Open
- 0.4698
- Previous close
- 0.4493
- Day's range
- 0.4301 – 0.4989
- 52-week range
- 0.4301 – 2.45
2Y -0.4280 (-48.09%)
Financials — quick view
RKTO Revenue — quarterly 0
RKTO Net income — quarterly -3.83M
RKTO EPS — quarterly -0.19
News
Rocket One's Hoth Therapeutics Subsidiary Plans To End Its Phase 2a Clinical Study Of HT-001 After Interim Efficacy Data; Intends To Seek FDA Feedback For Conducting HT-001 Into Potential Phase 3 Clinical Program 
Rocket One's Hoth Therapeutics Reports Strong HT-001 Efficacy Results, Ends Phase 2a Early and Plans to Pursue Phase 3 to Bring Treatment to Cancer Patients 
Rocket One Inks Patent License Deal With Department Of Air Force For Its Technology Designed To Capture Hostile Drones And Isolate Their Communications
Your note
Sign in to keep a note on RKTO — it syncs with the Stock Master app.